Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News OPTIMIZERx Corp OPRX

Healthcare Medical Devices
OptimizeRx Corporation is a digital health technology company enabling care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables... see more

Recent & Breaking News (NDAQ:OPRX)

OptimizeRx Acquires EvinceMed, a Specialty Drug Prescription Initiation Platform

GlobeNewswire March 15, 2022

OptimizeRx to Participate In-Person at 34th Annual ROTH Conference, March 13-15, 2022

GlobeNewswire March 7, 2022

OptimizeRx Reports Fourth Quarter and Full Year 2021 Financial Results, Revenue Increased 42%, Demand from Large Pharma Gains Momentum

GlobeNewswire February 24, 2022

Top 10 Pharma Deploys OptimizeRx's Digital Access Solution to Streamline Patient Therapy Initiation Challenges

GlobeNewswire February 22, 2022

OptimizeRx Announces Preliminary Fourth Quarter 2021 Financial Results, Introduces New Key Performance Indicators and Provides Initial 2022 Guidance

GlobeNewswire February 15, 2022

OptimizeRx Sets Fourth Quarter and Full Year 2021 Conference Call for Thursday, February 24 at 4:30 p.m. ET

GlobeNewswire February 10, 2022

OptimizeRx CEO, William Febbo, to Speak at the Bank of America Annual HCIT and Digital Health Conference

GlobeNewswire February 7, 2022

OptimizeRx's Mike Rousselle Named to MM+M's 40 Under 40 List of the Medical Marketing Industry's Brightest Young Stars

GlobeNewswire February 1, 2022

OptimizeRx to Participate in Upcoming February Investor Conferences

GlobeNewswire January 31, 2022

OptimizeRx's AI-Driven Therapy Initiation and Persistence Platform Wins 2022 BIG Innovation Award

GlobeNewswire January 18, 2022

OptimizeRx to Participate in Panel Presentation at LifeSci Partners Corporate Access Event 2022

GlobeNewswire January 3, 2022

OptimizeRx's Evidence-Based Physician Engagement Solution Named One of the Most Innovative Products of the Year by PM360

GlobeNewswire December 29, 2021

OptimizeRx CEO Issues Open Letter to Shareholders Detailing the Completion of Internal Management Changes

GlobeNewswire December 22, 2021

OptimizeRx Survey Addresses Treatment Selection, Discontinuation and Switching in Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer - an Indication with Limited Patient Population

GlobeNewswire December 15, 2021

OptimizeRx Recognized by Digital Health Awards® Fall 2021 for TelaRep(TM) and its COVID-19 Text Message Campaign

GlobeNewswire December 8, 2021

OptimizeRx Ranked Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500(TM)

GlobeNewswire November 23, 2021

OptimizeRx to Participate at the Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference

GlobeNewswire November 22, 2021

OptimizeRx and Reuters Events(TM) Team Up with I AM ALS and RESOLVE: The National Infertility Association for Innovate4Outcomes(TM)

GlobeNewswire November 16, 2021

OptimizeRx Reports Third Quarter 2021 Financial Results, Revenue Increased 53% in Continued Scale Up for Accelerated Growth

GlobeNewswire November 9, 2021

Predictive Analytics Solutions Create New Opportunities for Life Sciences to Address Delayed Diagnosis and other Challenges in Multiple Sclerosis Treatment

GlobeNewswire November 5, 2021